Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Evaluating the Role of Step Counts in Predicting Readmission and Mortality in Unplanned Hospitalized Cancer Patients: A Prospective Observational Study, STEP-CANCER

NCT06687330 is registered in ClinicalTrials.gov with Gazi University as lead sponsor.

NCT NCT06687330
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06687330 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Evaluating the Role of Step Counts in Predicting Readmission and Mortality in Unplanned Hospitalized Cancer Patients: A Prospective Observational Study, STEP-CANCER
Lead sponsor
Gazi University
Phase
Observational
Overall status
Completed
Start date
November 7, 2024
Completion date
August 15, 2025
Enrollment
220 (actual)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

exercise, quality of life (qol), rehospitalization, sleep quality, smart watch